COVID-19 and Respiratory Diseases Research Tools
Infectious diseases rank among the top respiratory system illnesses. The novel and resurfacing respiratory viral outbreaks have jeopardized public health and global economy. The coronavirus-associated epidemics like SARS (2003), MERS (2015), and COVID-19 (2019) have drawn attention to viral […]
CELLnTEC Joins PAST4FUTURE Consortium (2020)
CELLnTEC joins the PAST4FUTURE consortium to address organoids-based new research methods for skin diseases. Skin is the human body’s largest organ. Chronic, non-healing wounds are a significant problem for healthcare systems worldwide, accounting for 2–4% of healthcare […]
Meet Us at SID 2021 [United States] – Virtual/Online
You can connect with CELLnTEC representatives by visiting our virtual booth at the `Society for Investigative Dermatology`Annual Meeting between 3rd to 8th May 2021. Conference Link: SID 2021
Meet Us at IDC 2021 [JAPAN] – VIRTUAL/ONLINE
You can connect with CELLnTEC representatives by visiting our virtual booth at the `International Dermatology and Cosmetology` conference between 19 – 20th May 2021. Conference Link: IDC 2021
Meet Us at ESDR 2021 [Netherlands] – VIRTUAL/ONLINE
March 2, 2021
You can connect with CELLnTEC representatives by visiting our virtual booth at the `European Society for Dermatological Research` Annual Meeting between September 22 – 25th, 2021. Conference Link: ESDR 2021
Meet Us at TERMIS 2021 [NETHERLANDS]
March 1, 2021
Meet CELLnTEC representatives at the `Tissue Engineering and Regenerative Medicine` International conference at Maastricht (NL), between 15 – 19th November 2021. Conference Link: TERMIS 2021
Meet Us at TEDD Annual Meeting 2021 [Switzerland]
February 1, 2021
You can meet CELLnTEC representatives at the `Tissue Engineering for Drug Development and Substance Testing` annual meeting in Wädenswil, Switzerland on 14th October 2021. Conference Link: TEDD 2021
CELLnTEC launches 2D Co-culture starter kits
August 15, 2019
You can now successfully establish co-cultures of keratinocytes with fibroblast or melanocytes using CELLnTEC`s New PR2D-CC or PR2D-KM starter kits, respectively. Read More >
CELLnTEC appoints Thomas Schnibbe as Chief Executive Officer
January 8, 2018
Berne, Switzerland, January 8, 2018 – CELLnTEC Advanced Cell Systems is pleased to announce that Thomas Schnibbe, Ph.D, joined the company as Chief Executive Officer. Professor Eliane Müller, founder and President of CELLnTEC, says: “The board and me personally are […]